Question 1

How does Crotalaria retusa cause liver damage?

Accepted Answer

Crotalaria retusa contains pyrrolizidine alkaloids, primarily monocrotaline and retusamine, which are metabolized in the liver into reactive pyrrolic metabolites. These toxic compounds bind to cellular proteins and DNA, causing hepatocyte death, endothelial injury, and veno-occlusive disease. The resulting liver damage can progress to hepatic failure. This mechanism is well-documented in toxicology literature, making this herb one of the most hepatotoxic plants used in traditional medicine (Evidence Level C for traditional use context).

Question 2

Is Crotalaria retusa safe during pregnancy and breastfeeding?

Accepted Answer

Crotalaria retusa is unsafe during pregnancy and breastfeeding and must be strictly avoided. The pyrrolizidine alkaloids cross the placental barrier and are excreted in breast milk, potentially causing fetal hepatotoxicity, developmental abnormalities, and infant liver damage. No safe threshold exists. Pregnant and nursing women should not handle or use any preparations containing this herb due to the severity of potential adverse effects (Evidence Level C).

Question 3

What is the safe dosage of Crotalaria retusa?

Accepted Answer

No safe internal dosage exists for Crotalaria retusa due to its hepatotoxic pyrrolizidine alkaloids. Traditional use was limited to external applications for skin conditions, but even topical use requires extreme caution and professional supervision. Absorption through damaged skin can cause systemic toxicity. Internal consumption is absolutely contraindicated and has caused fatal veno-occlusive disease in documented cases. Avoid all unsupervised use (Evidence Level C, Traditional).

Question 4

Does Crotalaria retusa interact with medications?

Accepted Answer

Crotalaria retusa poses serious interaction risks due to its hepatotoxic compounds. Concurrent use with other hepatotoxic medications, including acetaminophen, isoniazid, methotrexate, and certain antifungals, may compound liver damage. Cytochrome P450-inducing drugs could increase metabolic activation of toxic alkaloids, worsening hepatotoxicity. Given the severe risks, any use alongside prescription medications requires professional oversight. Internal use should be avoided entirely (Evidence Level C).

Question 5

What are the side effects of Crotalaria retusa?

Accepted Answer

Crotalaria retusa causes severe hepatotoxicity, including hepatic veno-occlusive disease, which can progress to liver failure and death. Other serious effects include pulmonary hypertension, right heart failure, and respiratory complications. Chronic exposure leads to cumulative liver damage. Symptoms include abdominal pain, jaundice, ascites, and hepatomegaly. These effects are caused by pyrrolizidine alkaloids and can occur with relatively small doses. The risk-benefit profile strongly discourages any internal use (Evidence Level C).

Question 6

What is Crotalaria retusa used for in traditional medicine?

Accepted Answer

Crotalaria retusa has been used traditionally for respiratory conditions, skin diseases, and fever, primarily in tropical regions. However, these folk applications lack clinical evidence (Evidence Level C) and are considered dangerous due to the plant's hepatotoxic pyrrolizidine alkaloids. Modern herbal medicine strongly discourages its use regardless of indication. The documented risks of liver failure, pulmonary hypertension, and veno-occlusive disease far outweigh any potential traditional benefits.

Crotalaria retusa

Sources et citations

Résumé

Contexte

Usages traditionnels

Composés actifs

Mécanisme d'action

Preuves cliniques

Sécurité et effets indésirables

Synthèse des preuves

Sources PubMed

Sources gouvernementales